Vai al contenuto principale della pagina

Orphan Drugs in Epilepsy



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Nikanorova Marina Visualizza persona
Titolo: Orphan Drugs in Epilepsy Visualizza cluster
Pubblicazione: Montrouge, : JOHN LIBBEY EUROTEXT, 2014
Edizione: 1st ed.
Descrizione fisica: 1 online resource (90 p.)
Disciplina: 616.853
Soggetto topico: Epilepsy -- Treatment
Brain Diseases
Central Nervous System Agents
Drug Industry
Industry
Therapeutic Uses
Central Nervous System Diseases
Nervous System Diseases
Technology, Industry, and Agriculture
Pharmacologic Actions
Chemical Actions and Uses
Disease
Anticonvulsants
Epilepsy
Orphan Drug Production
Altri autori: JohannessenS. I  
GentonPierre  
Note generali: Description based upon print version of record.
Nota di contenuto: ""Orphan Drugs in Epilepsy""; ""Contents""; ""Foreword""; ""Bromides""; ""Adrenocorticotropic hormone and corticosteroids""; ""Stiripentol""; ""Felbamate""; ""Rufinamide""
Sommario/riassunto: Over half of epilepsies start before the age of 20 years and nearly 25% of them are refractory. A tiny proportion of them are even labelled a rare illness (ie: one affecting less than 200,000 people in the United States or less than 5 out of 10,000 people in the European Union). For these patients, two problems in their management arise: In children, seizures affect an immature brain and can impact its development. It is therefore essential to treat them so that brain development continues as normally as possible. The rarity of these syndromes does not encourage the pharmaceutical industry to invest in research. Therefore, there are few drugs available. However, a few target syndromes with a particularly unfavourable diagnosis. This work outlines 6 molecules in detail that are specifically used in epileptic encephalopathies. Every aspect of these molecules is discussed, including drug development, indication, efficacy, cost, etc. Drafted by international experts in the field of epileptology, it provides all the necessary information on orphan drugs and their clinical use.
Titolo autorizzato: Orphan Drugs in Epilepsy  Visualizza cluster
ISBN: 9782742012343
2742012346
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910972032203321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Serie: Topics in Epilepsy